Skip to main content
PTGX logo

PTGX · Protagonist Therapeutics, Inc · Share Buybacks

Track PTGX — free
$127.16 +2.49 (+2.00%) At close · Nov 18 Q4 2020 earnings call transcript
Market Cap
$8.30B
Shares
65.27M
Volume · Nov 18 433.18K Avg daily vol (3M) 666.83K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$300,000,000
as of 2026-09-08 · from 8-K (reviewed)
Remaining Authorization
$294,200,000
as of 2026-09-30
Program Utilization
1.9% $5,800,000 used of $300,000,000
Program Announced Authorized Remaining Runs Through
2026-09-08 $300,000,000 — —
Key facts CIK 1377121 CUSIP 74366E102 13F (30d) 382 filings 356 filers Visit website Investor relations